What is vilazodone, and why is stopping it harder than starting it?
Vilazodone, sold as Viibryd, is an antidepressant approved in the United States for major depressive disorder in adults. Its label says the antidepressant effect is thought to come from selective inhibition of serotonin reuptake, which is what makes a drug a selective serotonin reuptake inhibitor, or SSRI, and the label groups Viibryd with the SSRIs in its warnings. The label adds that it is also a partial agonist at one serotonin receptor, the 5-HT1A receptor, meaning it stimulates that receptor part of the way.
Starting it is simple. The label lays out a starting dose held for a week before the first step up, taken with food, and most prescribers follow it. Coming off of it is where the plan usually runs out.
Dr. Leeds is an osteopathic physician and deprescribing specialist in Fort Lauderdale, Florida, who helps patients taper off of antidepressants like this one. So, what does a careful vilazodone taper actually look like, and why does the label’s own advice fall short of it?
The label itself says that stopping abruptly can cause symptoms.
The Viibryd prescribing information has a section on discontinuation. It lists the reactions reported when serotonergic antidepressants are stopped, particularly when they are stopped abruptly: nausea, sweating, dysphoric mood, irritability, agitation, dizziness, sensory disturbances such as electric shock sensations, tremor, anxiety, confusion, headache, lethargy, emotional lability, insomnia, hypomania, tinnitus, and seizures.
That is the manufacturer’s list, not a patient forum’s. And, the instruction that follows it is plain: reduce the dose gradually rather than stopping abruptly, whenever possible.
Unfortunately, the label’s idea of gradual is short. Its own example of a step-down from the highest dose runs about a week from that dose to none, two steps and then nothing. For some people that is enough. For many, it is a cold turkey stop with a one-week delay.
Why would a drug you take for depression cause withdrawal at all?
Vilazodone raises the amount of serotonin available between nerve cells by blocking the transporter that would normally carry it back. Take it every day for months and the brain adapts to that new level. It adjusts its receptors and its own signaling until the presence of the drug is the new normal.
Remove the drug and the adaptation is still there, with nothing to balance it. That mismatch is physical dependence, and the symptoms on the label are the nervous system reporting it. The label gives vilazodone a terminal half-life of about 25 hours, so after an abrupt stop the drug is mostly gone within a few days, and that is when the reporting begins.
Dependence is not addiction. A person who takes vilazodone exactly as prescribed, never misuses it, and feels sick when it is stopped has a medical condition caused by the medication, not a character problem. The right treatment for that condition is a gradual, medically supervised taper, not a lecture and not an addiction program.
Why does the last step matter more than the first?
Here is the part that the one-week label taper misses. The relationship between the dose of an SSRI and how much of the serotonin transporter it occupies is not a straight line. The Maudsley Deprescribing Guidelines describe the curve as hyperbolic: the first few milligrams occupy a large share of the transporter, and each additional milligram adds less.
While this is not a perfect analogy, think of the volume knob on an old car stereo. Turning it from full down to half barely changes the room, and the last quarter turn is where every click is loud. Dose reductions on an SSRI behave the same way in reverse. Dropping from 40 mg to 20 mg changes what the brain feels far less than dropping from 10 mg to zero.
So, the last step is the loud one. A taper that cuts the same number of milligrams each time is gentle at the top and brutal at the bottom. The Maudsley approach is to make each reduction a proportion of the current dose, so the cuts get smaller in milligrams as the dose falls and the final dose before zero is very small, the same shape that makes a safe SSRI tapering schedule work for any drug in the class.
The tablets do not come in the sizes a careful taper needs.
Vilazodone comes as 10 mg, 20 mg, and 40 mg film-coated tablets. The smallest tablet is also the starting dose in the label’s own titration, which tells you something. The manufacturer built a starter step but not a finishing step.
Proportional cuts from 10 mg need doses of a few milligrams, and then a fraction of a milligram. No such tablet exists, and cutting a small film-coated tablet into eighths on the kitchen counter is not precision. It is guessing. There is no commercial liquid form in the United States either.
Fortunately, this problem has a solution that does not require heroics. A compounding pharmacy can prepare vilazodone as a liquid or as capsules in exact small strengths, so the bottom of the taper can be walked in small, measured steps rather than jumped. Your prescriber writes the prescription. The pharmacist does the arithmetic.
What does the shape of a careful taper look like?
It has three features: proportional reductions, holds, and a small final dose. The cut is a percentage of the current dose, not a fixed number of milligrams, and each cut is followed by a hold long enough for the nervous system to settle before the next one. How long that takes varies from person to person, which is why the plan is a shape and not a calendar.
Symptoms after a cut are information, not failure. If a reduction brings on the electric shock sensations, the dizziness, or the irritability from the label, that is the nervous system saying the step was too big or too soon. The answer is to hold, or to go back up one step, and then to take a smaller step next time. Holding is not weakness. It is the taper working as designed.
Faster is not stronger. Patients often describe pushing through a fast taper because they wanted to be done, and then spending months paying for the weeks they saved. A taper over several months, sometimes longer, is ordinary for a person who has taken the drug for years, and there is no prize for finishing early.
Is it withdrawal, or is the depression coming back?
This is a good question, and it is the one most likely to send a person back onto the drug for the wrong reason. Withdrawal symptoms tend to arrive within days of a cut and to include things depression never produced, such as the electric shock sensations, the dizziness, and the nausea. A return of depression tends to build over weeks and to feel like the original illness.
Yet, the two can overlap, and telling them apart is a job for you and your doctor together, not for you alone at two in the morning. If the symptoms follow a cut and ease when you hold, the taper was too fast. If they build slowly at a stable dose, the conversation is different. Either way, the decision about what to do next is yours to make with full information, and knowing what antidepressant withdrawal feels like makes that decision easier.
In fact, this is what informed consent was supposed to be from the beginning: the risks first, including dependence and withdrawal, the alternatives including no medication at all, an exit plan, and the right to say no at any point. If nobody had that conversation with you when the prescription was written, it is not too late to have it now, on the way out.
When should you call for help instead of waiting?
Most discontinuation symptoms are miserable rather than dangerous, and they respond to holding the dose. Two items on the label’s list are different. Hypomania and seizures are reasons to contact your prescriber promptly rather than to wait out the week, and the same is true of any symptom that frightens you.
If you have a seizure, or if you have thoughts of harming yourself, call 911 or go to the nearest emergency room, or call or text 988, the Suicide and Crisis Lifeline. A taper never asks you to tough out an emergency.
How does Dr. Leeds approach a vilazodone taper?
Dr. Leeds works with patients one on one by telemedicine throughout Florida, with weekly video visits and text access in between, so each reduction is judged on how the patient actually responded rather than on a schedule written in advance. Reductions are proportional, holds last as long as they need to, and compounded liquid or capsule forms are used when the tablets run out of useful sizes.
The pace is patient directed. If a step is too much, the plan slows down, and if a patient is comfortable and wants to move a bit faster, that is a conversation between equals, not an order. The goal is to get off of vilazodone once, and well, not by a date.
How long does it take to taper off of vilazodone?
Longer than the label’s week, and the honest answer is that it depends on how long you have taken it and how your nervous system responds to each cut. Several months is common for a person who has taken it for years, and the timeline adapts to you rather than the other way around.
What if someone has already stopped vilazodone abruptly and feels terrible?
The first call is to the prescriber, before anything else. The doctor may suggest going back to a dose that steadies things and tapering properly from there, and the sooner that conversation happens, the easier it usually is.
Does taking vilazodone with food matter during a taper?
Yes. The label says vilazodone should be taken with food because absorption falls without it, and during a taper a dose that is absorbed differently from one day to the next looks like a symptom spike that is not really there. Keep the routine the same every day.
If you are taking vilazodone and want to come off of it carefully, or you tried the one-week version and it did not go well, a physician who tapers antidepressants for a living can help you plan the shape of yours. Contact Dr. Leeds today to talk about tapering off of Viibryd.
This article is educational. It is not medical advice, and reading it does not create a doctor-patient relationship. Decisions about starting, continuing, or tapering any medication should be made with your own physician.
